References
- World Health Organization. Global Vaccine Action Plan 2011–2020. [accessed 2020 October 23]. http://www.who.int/immunization/global_vaccine_action_plan/GVAP_doc_2011_2020/en/
- Pan American Health Organization/World Health Organization (PAHO/WHO). Elimination of rubella and congenital rubella syndrome in the Americas. Fact sheet 2015. [accessed 2020 October 23]. https://www.paho.org/hq/dmdocuments/2015/rubella-elimination-factsheet-en.pdf
- Jindai K, Funaki T, Nishijima T, Takakura S, Noda H, Miyake K. Towards rubella elimination in Japan. Lancet Infect Dis. 2018;18(7):713–14. doi:10.1016/S1473-3099(18)30356-6.
- Sugishita Y, Shimatani N, Katow S, Takahashi T, Hori N. Epidemiological characteristics of rubella and congenital rubella syndrome in the 2012–2013 Epidemics in Tokyo, Japan. Jpn J Infect Dis. 2015;68(2):159–65. doi:10.7883/yoken.JJID.2014.195.
- Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Japan. Infectious diseases weekly report, report of congenital rubella syndrome. 2020 Jan 23 (Japanese). [accessed 2020 October 23]. https://www.niid.go.jp/niid/ja/rubella-m-111/700-idsc/8588-rubella-crs.html
- Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Japan. Infectious agents surveillance report Vol. 40 No. 8 (No. 474) 2019. [accessed 2020 October 23]. https://www.niid.go.jp/niid/images/idsc/iasr/40/474e.pdf
- Chiba City Infection Information Center. Epidemiological surveillance of infectious diseases in 2013 (Japanese). [accessed 2020 October 23]. https://www.city.chiba.jp/hokenfukushi/iryoeisei/khoken/kkagaku/idsc/documents/monthly_2013.pdf
- Chiba City, Rubella specific antibody testing for women who like to become pregnant and their families. 2019. (Japanese). [accessed 2020 October 23]. https://www.city.chiba.jp/hokenfukushi/iryoeisei/hokenjo/kansensho/seijin-rubella.html
- Ministry of Health, Labour and Welfare. Vaccination coverage for the first and second doses of Measles-Rubella vaccine. 2019. (Japanese). [accessed 2020 October 23]. https://www.mhlw.go.jp/bunya/kenkou/kekkaku-kansenshou21/hashika.html
- Nomoto H, Ishikane M, Nakamoto T, Ohta M, Morioka S, Yamamoto K, Kutsuna S, Tezuka S, Kunimatsu J, Ohmagari N. Conjunctivitis, the key clinical characteristic of adult rubella in Japan during two large outbreaks, 2012-2013 and 2018-2019. PLoS One. 2020;15:e0231966. doi:10.1371/journal.pone.0231966.
- Tago S, Hirai Y. A case of adult rubella in Japan. Int J Infect Dis. 2019;82:7–8. doi:10.1016/j.ijid.2019.02.034.
- Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Japan. National epidemiological surveillance of vaccine preventable diseases. Age distribution of rubella HI antibody positives in Japan, 2006-2018. [accessed 2020 October 23]. https://www.niid.go.jp/niid//images/epi/yosoku/2018/YearComparison/r2018year-e.pdf
- Hanaoka M, Hisano M, Watanabe N, Sugawara K, Kambe Y, Kanda E, Sago H, Kato T, Yamaguchi K. Changes in the prevalence of the measles, rubella, varicella-zoster, and mumps virus antibody titers in Japanese pregnant women. Vaccine. 2013;31(19):2343–47. doi:10.1016/j.vaccine.2013.03.012.
- Ogawa T, Inoue T, Kasahara K, Konishi M, Mikasa K. Impact of vaccination on measles, mumps, and rubella antibody titers in Japanese healthcare workers: an observational study. PLoS One. 2020;15(3):e0230329. doi:10.1371/journal.pone.0230329.
- Shoho Y, Kimura T, Yanagawa Y, Saito A, Inoue T, Suto C, Tsunekawa K, Araki O, Nara M, Tokue Y, et al. Vaccination status and antibody titers against rubella and measles among Japanese female college students majoring in childcare between 2015 and 2018. Tohoku J Exp Med. 2018;246(2):73–79. doi:10.1620/tjem.246.73.
- Katow S. Surveillance of congenital rubella syndrome in Japan, 1978–2002: effect of revision of the immunization law. Vaccine. 2004;22(29–30):4084–91. doi:10.1016/j.vaccine.2004.03.055.
- O’Connor C, Le Blanc D, Drew RJ. Epidemiological changes in rubella IgG antibody levels detected in antenatal women from a retrospective rubella seroprevalence study. Ir J Med Sci. 2018;187(3):689–92. doi:10.1007/s11845-017-1722-9.
- Takeuchi J, Goto M, Kawamura T, Hiraide A. Serological assessment of measles–rubella vaccination catch-up campaign among university students. Pediatr Int. 2014;56(3):395–99. doi:10.1111/ped.12285.
- Ministry of Health, Labour and Welfare. 34th health science council infectious diseases subcommittee. Rubella report. 2019:1–8. (Japanese). [accessed 2020 October 23]. https://www.mhlw.go.jp/content/10906000/000571663.pdf
- Sugishita Y, Soejima K, Kayebeta A, Yauchi M. Enhancing preparedness against rubella at the workplace: proactive prevention efforts by the Tokyo metropolitan government. Jpn J Infect Dis. 2019;72(4):250–55. doi:10.7883/yoken.JJID.2018.167.
- The Japan Times. Japan to offer men aged 39 to 56 free rubella vaccinations for three years to combat outbreak. The Japan Times News; 2018 Dec 11. [accessed 2020 October 23]. https://www.japantimes.co.jp/news/2018/12/11/national/science-health/japan-offer-men-aged-39-56-free-rubella-vaccinations-three-years-combat-outbreak/
- Hisano M, Kato T, Inoue E, Sago H, Yamaguchi K. Evaluation of measles–rubella vaccination for mothers in early puerperal phase. Vaccine. 2016;4(9):1208–14. doi:10.1016/j.vaccine.2016.01.015.